{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:21:36Z","timestamp":1767856896533,"version":"3.49.0"},"reference-count":108,"publisher":"Hindawi Limited","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/ijcp.12903","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T07:15:28Z","timestamp":1482995728000},"page":"967-977","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options"],"prefix":"10.1155","volume":"70","author":[{"given":"Panagiotis","family":"Anagnostis","sequence":"first","affiliation":[{"name":"Unit of Reproductive Endocrinology; First Department of Obstetrics and Gynecology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Karras","sequence":"additional","affiliation":[{"name":"Unit of Reproductive Endocrinology; First Department of Obstetrics and Gynecology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gynecology; National and Capodestrian University of Athens; Athens Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute; Imperial College London; Royal Brompton and Harefield NHS Foundation Trust; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[{"name":"Unit of Reproductive Endocrinology; First Department of Obstetrics and Gynecology; Medical School; Aristotle University of Thessaloniki; Thessaloniki Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"key":"10.1111\/ijcp.12903-BIB0001|ijcp12903-cit-0001","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198704303161801","article-title":"Menopause and the risk of coronary heart disease in women","volume":"316","author":"Colditz","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12903-BIB0002|ijcp12903-cit-0002","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-85-4-447","article-title":"Menopause and risk of cardiovascular disease: the Framingham study","volume":"85","author":"Kannel","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1111\/ijcp.12903-BIB0003|ijcp12903-cit-0003","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0022-2275(20)39173-2","article-title":"Effects of age, sex, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study","volume":"35","author":"Schaefer","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1111\/ijcp.12903-BIB0004|ijcp12903-cit-0004","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.maturitas.2015.02.262","article-title":"Effects of menopause, sex and age on lipids and high-density lipoprotein cholesterol subfractions","volume":"81","author":"Anagnostis","year":"2015","journal-title":"Maturitas"},{"key":"10.1111\/ijcp.12903-BIB0005|ijcp12903-cit-0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1089\/jwh.2012.4035","article-title":"Body fat distribution after menopause and cardiovascular disease risk factors: Korean National Health and Nutrition Examination Survey 2010","volume":"22","author":"Park","year":"2013","journal-title":"J Womens Health"},{"key":"10.1111\/ijcp.12903-BIB0006|ijcp12903-cit-0006","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.maturitas.2005.04.009","article-title":"The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy","volume":"53","author":"L\u00f8kkegaard","year":"2006","journal-title":"Maturitas"},{"key":"10.1111\/ijcp.12903-BIB0007|ijcp12903-cit-0007","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12903-BIB0008|ijcp12903-cit-0008","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/ijcp.12903-BIB0009|ijcp12903-cit-0009","first-page":"76","article-title":"Lipoprotein (a): structure, pathophysiology and clinical implications","volume":"103","author":"Maranh\u00e3o","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"10.1111\/ijcp.12903-BIB0010|ijcp12903-cit-0010","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1742-1241.2005.00442.x","article-title":"Lipoprotein(a) levels in patients with unstable angina and their relationship with atherothrombosis and myocardial damage","volume":"59","author":"Yazici","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12903-BIB0011|ijcp12903-cit-0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"key":"10.1111\/ijcp.12903-BIB0012|ijcp12903-cit-0012","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1155\/2013\/563717","article-title":"Lipoprotein(a): a promising marker for residual cardiovascular risk assessment","volume":"35","author":"Cai","year":"2013","journal-title":"Dis Markers"},{"key":"10.1111\/ijcp.12903-BIB0013|ijcp12903-cit-0013","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3346\/jkms.2000.15.4.380","article-title":"Influence of menopause on high density lipoprotein-cholesterol and lipids","volume":"15","author":"Kim","year":"2000","journal-title":"J Korean Med Sci"},{"key":"10.1111\/ijcp.12903-BIB0014|ijcp12903-cit-0014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2004-814450","article-title":"Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution","volume":"36","author":"Berg","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1111\/ijcp.12903-BIB0015|ijcp12903-cit-0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-2006-950504","article-title":"Serum lipoprotein(a) dynamics before\/after menopause and long-term effects of hormone replacement therapy on lipoprotein(a) levels in middle-aged and older Japanese women","volume":"38","author":"Ushioda","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1111\/ijcp.12903-BIB0016|ijcp12903-cit-0016","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0378-5122(03)00045-8","article-title":"Comparison of forearm endothelial function between premenopausal and postmenopausal women with or without hypercholesterolemia","volume":"44","author":"Sanada","year":"2003","journal-title":"Maturitas"},{"key":"10.1111\/ijcp.12903-BIB0017|ijcp12903-cit-0017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0378-5122(99)00054-7","article-title":"Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity","volume":"33","author":"Abbey","year":"1999","journal-title":"Maturitas"},{"key":"10.1111\/ijcp.12903-BIB0018|ijcp12903-cit-0018","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.CIR.87.4.1135","article-title":"Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study","volume":"87","author":"Jenner","year":"1993","journal-title":"Circulation"},{"key":"10.1111\/ijcp.12903-BIB0019|ijcp12903-cit-0019","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11745-010-3513-1","article-title":"Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes","volume":"46","author":"Nakhjavani","year":"2011","journal-title":"Lipids"},{"key":"10.1111\/ijcp.12903-BIB0020|ijcp12903-cit-0020","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.168.6.598","article-title":"Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data","volume":"168","author":"Bennet","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1111\/ijcp.12903-BIB0021|ijcp12903-cit-0021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1567-5688(09)71817-3","article-title":"Cardiovascular events in patients with increased lipoprotein (a) - retrospective data analysis in an outpatient department of lipid disorders","volume":"10","author":"Tselmin","year":"2009","journal-title":"Atheroscler Suppl"},{"key":"10.1111\/ijcp.12903-BIB0022|ijcp12903-cit-0022","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","article-title":"Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis","volume":"242","author":"Nave","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1111\/ijcp.12903-BIB0023|ijcp12903-cit-0023","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1111\/ijcp.12903-BIB0024|ijcp12903-cit-0024","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1111\/ijcp.12903-BIB0025|ijcp12903-cit-0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.18.S1.1","article-title":"AACE Task Force for Management of Dyslipidemia and Prevention of Atherosclerosis. American Association of Clinical Endocrinologists\u2019 Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis","volume":"18","author":"Jellinger","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1111\/ijcp.12903-BIB0026|ijcp12903-cit-0026","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Gidding","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1111\/ijcp.12903-BIB0027|ijcp12903-cit-0027","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/01.ATV.13.7.1037","article-title":"Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study","volume":"13","author":"Marcovina","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1111\/ijcp.12903-BIB0028|ijcp12903-cit-0028","doi-asserted-by":"crossref","first-page":"e14581","DOI":"10.1371\/journal.pone.0014581","article-title":"Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans","volume":"6","author":"Deo","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1111\/ijcp.12903-BIB0029|ijcp12903-cit-0029","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"key":"10.1111\/ijcp.12903-BIB0030|ijcp12903-cit-0030","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis","volume":"35","author":"Guan","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/ijcp.12903-BIB0031|ijcp12903-cit-0031","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1194\/jlr.M012526","article-title":"Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study","volume":"52","author":"Lamon-Fava","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1111\/ijcp.12903-BIB0032|ijcp12903-cit-0032","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.ATV.17.2.239","article-title":"A prospective case-control study of lipoprotein(a) levels and apo(a) size and risk of coronary heart disease in Stanford Five-City Project participants","volume":"17","author":"Wild","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/ijcp.12903-BIB0033|ijcp12903-cit-0033","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.296.11.1363","article-title":"Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women","volume":"296","author":"Suk Danik","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12903-BIB0034|ijcp12903-cit-0034","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0021-9150(98)00275-5","article-title":"Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan","volume":"143","author":"Yamamoto","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1111\/ijcp.12903-BIB0035|ijcp12903-cit-0035","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0022-2275(20)37553-2","article-title":"Effects of sex and menopausal status on plasma lipoprotein subspecies and particle sizes","volume":"37","author":"Li","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1111\/ijcp.12903-BIB0036|ijcp12903-cit-0036","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0029-7844(96)00349-3","article-title":"Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy","volume":"88","author":"Bruschi","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1111\/ijcp.12903-BIB0037|ijcp12903-cit-0037","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0895-4356(93)90034-X","article-title":"Lipoprotein (a) in a randomly selected 25-64\u00a0year old population: the Northern Sweden Monica Study","volume":"46","author":"Slunga","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/ijcp.12903-BIB0038|ijcp12903-cit-0038","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.283.14.1845","article-title":"Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause","volume":"283","author":"Shlipak","year":"2000","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12903-BIB0039|ijcp12903-cit-0039","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-5122(01)00223-7","article-title":"Triglyceride and lipoprotein (a) are markers of coronary artery disease severity among postmenopausal women","volume":"39","author":"Sposito","year":"2001","journal-title":"Maturitas"},{"key":"10.1111\/ijcp.12903-BIB0040|ijcp12903-cit-0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0735-1097(99)00555-0","article-title":"Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women","volume":"35","author":"Nishino","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12903-BIB0041|ijcp12903-cit-0041","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0002-9378(11)90604-8","article-title":"Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen","volume":"166","author":"Lobo","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/ijcp.12903-BIB0042|ijcp12903-cit-0042","doi-asserted-by":"crossref","first-page":"e0137154","DOI":"10.1371\/journal.pone.0137154","article-title":"Correction: associations of low-intensity resistance training with body composition and lipid profile in obese patients with type 2 diabetes","volume":"10","author":"Hamasaki","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1111\/ijcp.12903-BIB0043|ijcp12903-cit-0043","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00404-006-0187-2","article-title":"The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women","volume":"274","author":"Bayrak","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"10.1111\/ijcp.12903-BIB0044|ijcp12903-cit-0044","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/09513590410001715207","article-title":"Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women","volume":"18","author":"Christodoulakos","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"10.1111\/ijcp.12903-BIB0045|ijcp12903-cit-0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000211676","article-title":"Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause","volume":"68","author":"Perrone","year":"2009","journal-title":"Gynecol Obstet Invest"},{"key":"10.1111\/ijcp.12903-BIB0046|ijcp12903-cit-0046","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/13697130500345190","article-title":"1 and 2\u00a0mg 17\u03b2-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women","volume":"8","author":"Stevenson","year":"2005","journal-title":"Climacteric"},{"key":"10.1111\/ijcp.12903-BIB0047|ijcp12903-cit-0047","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1111\/ijcp.12903-BIB0048|ijcp12903-cit-0048","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1463-1326.2005.00545.x","article-title":"Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women","volume":"8","author":"Salpeter","year":"2006","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/ijcp.12903-BIB0049|ijcp12903-cit-0049","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1538-7836.2008.02970.x","article-title":"Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers","volume":"6","author":"Eilertsen","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/ijcp.12903-BIB0050|ijcp12903-cit-0050","doi-asserted-by":"crossref","first-page":"15569","DOI":"10.1074\/jbc.274.22.15569","article-title":"Estrogen modulation of apolipoprotein(a) expression. Identification of a regulatory element","volume":"274","author":"Boffelli","year":"1999","journal-title":"J\u00a0Biol Chem"},{"key":"10.1111\/ijcp.12903-BIB0051|ijcp12903-cit-0051","first-page":"3267","article-title":"Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement","volume":"83","author":"Su","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/ijcp.12903-BIB0052|ijcp12903-cit-0052","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-5122(03)00085-9","article-title":"Does the beneficial effect of HRT on endothelial function depend on lipid changes","volume":"45","author":"Ossewaarde","year":"2003","journal-title":"Maturitas"},{"key":"10.1111\/ijcp.12903-BIB0053|ijcp12903-cit-0053","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jacc.2008.04.009","article-title":"Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events","volume":"52","author":"Suk Danik","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12903-BIB0054|ijcp12903-cit-0054","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","article-title":"Tibolone for postmenopausal women: systematic review of randomized trials","volume":"87","author":"Modelska","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/ijcp.12903-BIB0055|ijcp12903-cit-0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1530\/acta.0.1280259","article-title":"Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women","volume":"128","author":"Rymer","year":"1993","journal-title":"Acta Endocrinol"},{"key":"10.1111\/ijcp.12903-BIB0056|ijcp12903-cit-0056","first-page":"645","article-title":"Postmenopausal hormone replacement therapy with Tibolone decreases serum lipoprotein(a)","volume":"31","author":"Haenggi","year":"1993","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1111\/ijcp.12903-BIB0057|ijcp12903-cit-0057","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2015.06.056","article-title":"Tibolone decreases lipoprotein(a) levels in postmenopausal women: a systematic review and meta-analysis of 12 studies with 1009 patients","volume":"242","author":"Kotani","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1111\/ijcp.12903-BIB0058|ijcp12903-cit-0058","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1067\/mob.2000.106769","article-title":"Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy","volume":"183","author":"D\u00f6ren","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/ijcp.12903-BIB0059|ijcp12903-cit-0059","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.jhh.1000938","article-title":"A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women","volume":"14","author":"Lloyd","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1111\/ijcp.12903-BIB0060|ijcp12903-cit-0060","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1210\/jcem.82.6.3995","article-title":"Tibolone: influence on markers of cardiovascular disease","volume":"82","author":"Bjarnason","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/ijcp.12903-BIB0061|ijcp12903-cit-0061","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1471-0528.1997.tb11982.x","article-title":"Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study","volume":"104","author":"H\u00e4nggi","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1111\/ijcp.12903-BIB0062|ijcp12903-cit-0062","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.metabol.2012.07.024","article-title":"Lipoprotein(a) metabolism: potential sites for therapeutic targets","volume":"62","author":"Hoover-Plow","year":"2013","journal-title":"Metabolism"},{"key":"10.1111\/ijcp.12903-BIB0063|ijcp12903-cit-0063","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng0495-424","article-title":"The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice","volume":"9","author":"Frazer","year":"1995","journal-title":"Nat Genet"},{"key":"10.1111\/ijcp.12903-BIB0064|ijcp12903-cit-0064","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosissup.2015.02.008","article-title":"Lowering of lipoprotein(a) level under niacin treatment is dependent on apolipoprotein(a) phenotype","volume":"18","author":"Artemeva","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"10.1111\/ijcp.12903-BIB0065|ijcp12903-cit-0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/eci.12095","article-title":"Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial","volume":"43","author":"Kei","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/ijcp.12903-BIB0066|ijcp12903-cit-0066","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2013.06.051","article-title":"Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (atherothrombosis intervention in metabolic syndrome with low HDL\/high triglyceride and impact on global health outcomes)","volume":"62","author":"Albers","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12903-BIB0067|ijcp12903-cit-0067","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.metabol.2013.10.014","article-title":"Effect of nicotinic acid\/laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype","volume":"63","author":"Cenarro","year":"2014","journal-title":"Metabolism"},{"key":"10.1111\/ijcp.12903-BIB0068|ijcp12903-cit-0068","doi-asserted-by":"crossref","first-page":"306147","DOI":"10.1155\/2010\/306147","article-title":"The effects of extended release niacin in combination with omega 3 fatty acid supplements in the treatment of elevated lipoprotein (a)","volume":"2010","author":"Helmbold","year":"2010","journal-title":"Cholesterol"},{"key":"10.1111\/ijcp.12903-BIB0069|ijcp12903-cit-0069","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jacl.2014.03.006","article-title":"Dramatic lowering of very high Lp(a) in response to niacin","volume":"8","author":"Li","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1111\/ijcp.12903-BIB0070|ijcp12903-cit-0070","doi-asserted-by":"crossref","first-page":"20B","DOI":"10.1016\/j.amjcard.2008.02.029","article-title":"Mechanism of action of niacin","volume":"101","author":"Kamanna","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12903-BIB0071|ijcp12903-cit-0071","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/ATVBAHA.115.305835","article-title":"Effects of extended-release nicotinic acid on apolipoprotein (a) kinetics in hypertriglyceridemic patients","volume":"35","author":"Croyal","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/ijcp.12903-BIB0072|ijcp12903-cit-0072","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1161\/ATVBAHA.115.306136","article-title":"Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus","volume":"35","author":"Ooi","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/ijcp.12903-BIB0073|ijcp12903-cit-0073","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.atherosclerosis.2009.12.023","article-title":"Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis","volume":"210","author":"Bruckert","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1111\/ijcp.12903-BIB0074|ijcp12903-cit-0074","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12903-BIB0075|ijcp12903-cit-0075","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/eurheartj\/eht055","article-title":"HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin\/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment","volume":"34","author":"HPS2-THRIVE Collaborative Group","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1111\/ijcp.12903-BIB0076|ijcp12903-cit-0076","unstructured":"Niacin\/laropiprant products to be withdrawn in EU next week. Medscape http:\/\/www.medscape.com\/viewarticle\/777870"},{"key":"10.1111\/ijcp.12903-BIB0077|ijcp12903-cit-0077","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0021-9150(02)00072-2","article-title":"Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk","volume":"164","author":"Gonbert","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1111\/ijcp.12903-BIB0078|ijcp12903-cit-0078","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/heart.89.8.893","article-title":"Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia","volume":"89","author":"Wissen","year":"2003","journal-title":"Heart"},{"key":"10.1111\/ijcp.12903-BIB0079|ijcp12903-cit-0079","first-page":"380","article-title":"The comparison of simvastatin and atorvastatin effects on hemostatic parameters in patients with hyperlipidemia type II","volume":"18","author":"Broncel","year":"2005","journal-title":"Pol Merkur Lekarski"},{"key":"10.1111\/ijcp.12903-BIB0080|ijcp12903-cit-0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1399-0004.1997.tb04342.x","article-title":"Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study","volume":"52","author":"Berg","year":"1997","journal-title":"Clin Genet"},{"key":"10.1111\/ijcp.12903-BIB0081|ijcp12903-cit-0081","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.mayocp.2013.09.003","article-title":"Lipoprotein(a), cardiovascular disease, and contemporary management","volume":"88","author":"Jacobson","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/ijcp.12903-BIB0082|ijcp12903-cit-0082","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.atherosclerosis.2015.07.024","article-title":"Lipoprotein (a) levels are not associated with carotid plaques and carotid intima media thickness in statin-treated patients with familial hypercholesterolemia","volume":"242","author":"Bos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1111\/ijcp.12903-BIB0083|ijcp12903-cit-0083","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.jacc.2013.07.056","article-title":"Targeting the proprotein convertase subtilisin\/kexin type 9 for the treatment of dyslipidemia and atherosclerosis","volume":"62","author":"Urban","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12903-BIB0084|ijcp12903-cit-0084","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12903-BIB0085|ijcp12903-cit-0085","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12903-BIB0086|ijcp12903-cit-0086","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.amjcard.2014.05.060","article-title":"Effect of alirocumab, a monoclonal proprotein convertase subtilisin\/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150\u00a0mg every two weeks dosing from phase 2 trials)","volume":"114","author":"Gaudet","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1111\/ijcp.12903-BIB0087|ijcp12903-cit-0087","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2014.01.006","article-title":"Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials","volume":"63","author":"Raal","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/ijcp.12903-BIB0088|ijcp12903-cit-0088","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.metabol.2015.01.009","article-title":"The effects of estrogen on serum level and hepatocyte expression of PCSK9","volume":"64","author":"Guo","year":"2015","journal-title":"Metabolism"},{"key":"10.1111\/ijcp.12903-BIB0089|ijcp12903-cit-0089","unstructured":"Approve PCSK9 Inhibitor Evolocumab, FDA Panel Recommends http:\/\/www.medscape.com\/viewarticle\/846236"},{"key":"10.1111\/ijcp.12903-BIB0090|ijcp12903-cit-0090","unstructured":"FDA approves new LDL-lowering agent alirocumab (Praluent) http:\/\/www.medscape.com\/viewarticle\/848535"},{"key":"10.1111\/ijcp.12903-BIB0091|ijcp12903-cit-0091","unstructured":"EU approves PCSK9 inhibitor Evolocumab (Repatha) http:\/\/www.medscape.com\/viewarticle\/848370"},{"key":"10.1111\/ijcp.12903-BIB0092|ijcp12903-cit-0092","unstructured":"EMA Committee Backs Approval of PCSK9 Inhibitor Alirocumab (Praluent) http:\/\/www.medscape.com\/viewarticle\/848595"},{"key":"10.1111\/ijcp.12903-BIB0093|ijcp12903-cit-0093","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/CRD.0b013e31823424be","article-title":"Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemia","volume":"20","author":"Ricotta","year":"2012","journal-title":"Cardiol Rev"},{"key":"10.1111\/ijcp.12903-BIB0094|ijcp12903-cit-0094","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/ATVBAHA.114.304549","article-title":"Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials","volume":"35","author":"Santos","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/ijcp.12903-BIB0095|ijcp12903-cit-0095","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40256-014-0077-0","article-title":"Mipomersen is a promising therapy in the management of hypercholesterolemia: a meta-analysis of randomized controlled trials","volume":"14","author":"Li","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1111\/ijcp.12903-BIB0096|ijcp12903-cit-0096","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1194\/jlr.R017855","article-title":"Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk","volume":"52","author":"Calandra","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1111\/ijcp.12903-BIB0097|ijcp12903-cit-0097","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1111\/ijcp.12903-BIB0098|ijcp12903-cit-0098","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ncpcardio1250","article-title":"Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia","volume":"5","author":"Samaha","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1111\/ijcp.12903-BIB0099|ijcp12903-cit-0099","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.2174\/1381612811319170022","article-title":"The promise of cholesteryl ester transfer protein (CETP) inhibition in the treatment of cardiovascular disease","volume":"19","author":"Bochem","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1111\/ijcp.12903-BIB0100|ijcp12903-cit-0100","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12903-BIB0101|ijcp12903-cit-0101","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12903-BIB0102|ijcp12903-cit-0102","unstructured":"Lilly pulls plug on its CETP inhibitor evacetrapib http:\/\/www.medscape.com\/viewarticle\/852516"},{"key":"10.1111\/ijcp.12903-BIB0103|ijcp12903-cit-0103","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1194\/jlr.M057794","article-title":"Anacetrapib reduces (V)LDL-cholesterol by inhibition of CETP activity and reduction of plasma PCSK9","volume":"56","author":"Tuin","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1111\/ijcp.12903-BIB0104|ijcp12903-cit-0104","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-8587(14)70006-3","article-title":"Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study","volume":"2","author":"Sjouke","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1111\/ijcp.12903-BIB0105|ijcp12903-cit-0105","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0905633","article-title":"Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia","volume":"362","author":"Ladenson","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/ijcp.12903-BIB0106|ijcp12903-cit-0106","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.atherosclerosissup.2015.02.040","article-title":"The incidence of cardiovascular events is largely reduced in patients with maximally tolerated drug therapy and lipoprotein apheresis. A single-center experience","volume":"18","author":"Sampietro","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"10.1111\/ijcp.12903-BIB0107|ijcp12903-cit-0107","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1742-1241.2007.01488.x","article-title":"LDL-apheresis: indications and clinical experience in a tertiary cardiac centre","volume":"61","author":"Archontakis","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1111\/ijcp.12903-BIB0108|ijcp12903-cit-0108","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12903","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12903","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.12903\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T04:57:33Z","timestamp":1658293053000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":108,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12903","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}